Standard BioTools Inc.
LAB
$1.29
-$0.04-3.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | 19.04% | -72.29% | -28.29% | -- |
| Total Depreciation and Amortization | -- | -19.70% | 1.20% | -33.56% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | 55.16% | -- |
| Total Other Non-Cash Items | -- | 155.12% | 83.89% | 21.05% | -- |
| Change in Net Operating Assets | -- | 30.68% | 412.35% | -1,574.34% | -- |
| Cash from Operations | 47.07% | 51.53% | 0.01% | -144.21% | -318.59% |
| Capital Expenditure | -- | -547.12% | -4,235.90% | -149.17% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -49.31% | 333.86% | 41.60% | -- |
| Cash from Investing | -45.27% | -95.40% | 296.13% | 38.14% | 25.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -4,300.00% | 100.00% | -- |
| Issuance of Common Stock | -- | -- | 24.70% | -15.00% | -- |
| Repurchase of Common Stock | -- | 99.58% | 74.14% | 82.97% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.38% | 99.77% | -5,335.69% | 99.83% | -1,260.89% |
| Foreign Exchange rate Adjustments | -- | 1,800.00% | -216.09% | -177.55% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 144.84% | -106.51% | -54.27% | 5.57% | -160.21% |